MOCHIDA PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,205 JPY | +0.47% |
|
+1.26% | -1.99% |
| Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
| Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
Evolution of the average Target Price on Mochida Pharmaceutical Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
9145d44abd8d4097d44b9953c6c.mkkwORoIokr5kHoY-bCWzuIcEUA09eOJNYx5XfOkri4.whoATm9-zw6LqTFpit3JqNFdZXNnh5vOcecPPsGX72eqLl1aXFr4crPbLw~05edf358101a178559ac14c471eb8b6c
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3,190
JPY
Average target price
3,200
JPY
Spread / Average Target
+0.31%
High Price Target
3,200
JPY
Spread / Highest target
+0.31%
Low Price Target
3,200
JPY
Spread / Lowest Target
+0.31%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 4534 Stock
- Consensus Mochida Pharmaceutical Co., Ltd.
